FDA welcomes Committee on Standards in Public Life recommendations for Ministerial Code reform

FDA General Secretary Dave Penman welcomed the “comprehensive report” from the Committee on Standards in Public Life on Upholding Standards in Public Life, saying it details “where urgent action is needed to restore public faith in those either elected or appointed to serve the public’s interests”.
Penman argued that the report’s nine recommendations on the Ministerial Code “could not come at a more opportune time”, with the FDA’s recent survey of members showing that 85% of senior civil servants – those working closest to ministers – had no faith in the code as a means of regulation of ministerial behaviour.
He also told the Guardian that “there can be no hiding from the fact that the current Prime Minister has undermined confidence in the Ministerial Code as a meaningful regulator of ministerial conduct”, but pointed out that existing arrangements already fell short of the independence required to be effective:
“As the committee recognises, the independent process that has now been established in Parliament, whilst far from perfect, provides a model for the approach that the public can rightly expect to regulating and enforcing standards on those they elect to serve their interests.”
Related News
-

FDA condemns dismissal of Sir Olly Robbins over Mandelson vetting
The FDA has condemned the Prime Minister’s dismissal of Sir Olly Robbins, former FCDO Permanent Secretary, over the vetting of Lord Mandelson for his appointment as Ambassador to the United States.
-

Never again
Following the unacceptable issues arising from the civil service pension scheme transfer to Capita, Adrian Prandle outlines the FDA’s ongoing work to ensure members get the support they need as quickly as possible.
-

Shaping the world of work: Dave Penman on the challenges facing the civil service, and plans for his new term as General Secretary
Following his re-election, Dave Penman outlines the challenges of the next five years and his plans to improve the working lives of FDA’s members.